Insider · CIK 0001271244

CHRISTOPHER RICHARD

Reports to the SEC for 5 companies · WILMINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001271244

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-29	LEXXLexaria Bioscience Corp.P Purchase	Director, Chief Executive Officer	PPurchase	+15K sh	$0.91	+$13.6K	65,000
2025-05-15	LEXXLexaria Bioscience Corp. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	350,000
2024-12-03	LEXXLexaria Bioscience Corp.P Purchase	Director, Chief Executive Officer	PPurchase	+27.2K sh	$2.47	+$67.2K	50,000
2024-12-02	LEXXLexaria Bioscience Corp.P Purchase	Director, Chief Executive Officer	PPurchase	+22.8K sh	$2.24	+$51.2K	22,828
2022-11-17	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+20.8K sh	—	—	20,800
2021-03-18	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2020-03-10	INVIVO THERAPEUTICS HOLDINGS CORP.Warrant (right to buy)P Purchase	Chief Financial Officer	PPurchase	+3,636 sh	—	—	3,636
2020-03-10	INVIVO THERAPEUTICS HOLDINGS CORP.P Purchase	Chief Financial Officer	PPurchase	+3,636 sh	—	—	5,220
2019-09-25	INVIVO THERAPEUTICS HOLDINGS CORP.A Award	Chief Financial Officer	AAward	+47.5K sh	—	—	47,500
2019-01-14	INVIVO THERAPEUTICS HOLDINGS CORP.Nonstatutory Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+90K sh	—	—	90,000
2018-12-21	ICAD INCConvertible DebentureA Award	Executive VP and CFO	AAward	+5,000 sh	$4.00	+$20K	5,000
2018-12-05	ICAD INCF Tax Payment	Executive VP and CFO	FTax Payment	−4,909 sh	$4.08	−$20K	117,854
2018-03-30	ICAD INCF Tax Payment	Executive VP and CFO	FTax Payment	−6,735 sh	$3.08	−$20.7K	122,763
2018-03-30	ICAD INCA Award	Executive VP and CFO	AAward	+58.3K sh	$3.08	+$180K	129,498
2018-03-22	ICAD INCA Award	Executive VP and CFO	AAward	+25K sh	—	—	71,165
2017-12-05	ICAD INCF Tax Payment	Executive VP and CFO	FTax Payment	−5,409 sh	$3.52	−$19K	46,165
2017-05-04	ICAD INCA Award	Executive VP and CFO	AAward	+1,574 sh	—	—	51,574
2016-12-05	ICAD INCA Award	Executive VP and CFO	AAward	+50K sh	—	—	50,000
2012-12-20	DUSA PHARMACEUTICALS INCU Disposition from Tender	VP Finance & CFO	UDisposition from Tender	−66.9K sh	$8.00	−$535K	0
2012-12-20	DUSA PHARMACEUTICALS INCU Disposition from Tender	VP Finance & CFO	UDisposition from Tender	−209K sh	$8.00	−$1.67M	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−20K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−25K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−20K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−20K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−19.5K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−37.6K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	VP Finance & CFO	DDisposition to Issuer	−85K sh	—	—	0
2012-11-13	DUSA PHARMACEUTICALS INCIncentive Stock OptionM Exercise/Conversion	VP Finance & CFO	MExercise/Conversion	−7,500 sh	—	—	0
2012-11-13	DUSA PHARMACEUTICALS INCM Exercise/Conversion	VP Finance & CFO	MExercise/Conversion	+7,500 sh	$1.60	+$12K	276,012
2012-05-09	DUSA PHARMACEUTICALS INCF Tax Payment	VP Finance & CFO	FTax Payment	−1,030 sh	$6.13	−$6,313.9	268,512
2012-03-13	DUSA PHARMACEUTICALS INCF Tax Payment	VP Finance & CFO	FTax Payment	−2,980 sh	$5.86	−$17.5K	269,542
2012-03-08	DUSA PHARMACEUTICALS INCA Award	VP Finance & CFO	AAward	+130K sh	—	—	272,522
2012-03-07	DUSA PHARMACEUTICALS INCF Tax Payment	VP Finance & CFO	FTax Payment	−5,151 sh	$6.05	−$31.2K	142,522
2012-03-05	DUSA PHARMACEUTICALS INCF Tax Payment	VP Finance & CFO	FTax Payment	−3,329 sh	$4.65	−$15.5K	147,673
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−15K sh	$5.94	−$89K	163,552
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−2,500 sh	$5.91	−$14.8K	161,052
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−5,000 sh	$5.91	−$29.5K	156,052
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−50 sh	$5.89	−$294.5	156,002
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−5,000 sh	$5.90	−$29.5K	151,002
2011-05-12	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionM Exercise/Conversion	VP Finance & CFO	MExercise/Conversion	−37.6K sh	—	—	0
2011-05-12	DUSA PHARMACEUTICALS INCIncentive Stock OptionM Exercise/Conversion	VP Finance & CFO	MExercise/Conversion	−5,000 sh	—	—	0
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−700 sh	$5.99	−$4,193	192,852
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−300 sh	$5.98	−$1,794.9	192,452
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−6,900 sh	$5.98	−$41.3K	185,552
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−500 sh	$5.97	−$2,987.5	185,052
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−4,400 sh	$5.97	−$26.3K	180,652
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−1,800 sh	$5.96	−$10.7K	178,852
2011-05-12	DUSA PHARMACEUTICALS INCS Sale	VP Finance & CFO	SSale	−300 sh	$5.95	−$1,785	178,552
2011-05-12	DUSA PHARMACEUTICALS INCM Exercise/Conversion	VP Finance & CFO	MExercise/Conversion	+37.6K sh	$1.22	+$45.8K	188,552
2011-05-12	DUSA PHARMACEUTICALS INCM Exercise/Conversion	VP Finance & CFO	MExercise/Conversion	+5,000 sh	$3.87	+$19.4K	193,552

Recent filings

Accepted (ET)
Jul 304
CHRISTOPHER RICHARD0001348362-25-000012
SEC(opens sec.gov)
May 164
CHRISTOPHER RICHARD0001348362-25-000011
SEC(opens sec.gov)
Dec 34
CHRISTOPHER RICHARD0001348362-24-000006
SEC(opens sec.gov)
Nov 214
CHRISTOPHER RICHARD0001104659-22-120834
SEC(opens sec.gov)
Mar 224
CHRISTOPHER RICHARD0001179110-21-003704
SEC(opens sec.gov)
Mar 124
CHRISTOPHER RICHARD0001179110-20-003590
SEC(opens sec.gov)
Sep 274
CHRISTOPHER RICHARD0001179110-19-010713
SEC(opens sec.gov)
Jan 164
CHRISTOPHER RICHARD0001179110-19-000766
SEC(opens sec.gov)
Dec 274
CHRISTOPHER RICHARD0000899243-18-031822
SEC(opens sec.gov)
Dec 64
CHRISTOPHER RICHARD0000749660-18-000053
SEC(opens sec.gov)
Apr 24
CHRISTOPHER RICHARD0000749660-18-000020
SEC(opens sec.gov)
Mar 284
CHRISTOPHER RICHARD0000749660-18-000018
SEC(opens sec.gov)
Dec 74
CHRISTOPHER RICHARD0000749660-17-000026
SEC(opens sec.gov)
May 84
ICAD INC0001593968-17-000672
SEC(opens sec.gov)
Dec 64
ICAD INC0001593968-16-001275
SEC(opens sec.gov)
Dec 204
CHRISTOPHER RICHARD0001209191-12-058853
SEC(opens sec.gov)

Companies

Address

C/O DUSA PHARMACEUTICALS, INC. 25 UPTON DRIVE

WILMINGTON, MA, 01887